Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT01863550 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01863550
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-06
- Primary completion
- 2026-12-31
- Enrollment
- 1087
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.